Click a link below to view the mailing archive as if it had been sent to you.
| 2013-09-30 12:15 | | KCI, LifeCell and Systagenix to Form One Company Focused on Transformational Healing Solutions under the Leadership of P... and more... |
| 2013-09-30 00:15 | | Indian pharma market isnâÔö£é?öé??Ôö£é?ö?ñót going to be that rosy and more... |
| 2013-09-29 00:15 | | 3 Signs We Could Be Entering a Biotech Bubble and more... |
| 2013-09-28 12:15 | | Lilly Disappointed in Medicare Decision to Deny Appropriate Patient Access to Beta-Amyloid Imaging Agents, Including Amy... and more... |
| 2013-09-28 00:15 | | Actos jury says Takeda failed at safety warnings, but judge tosses $1.7M verdict and more... |
| 2013-09-27 12:15 | | US approves Mylan's purchase of Strides unit, with conditions and more... |
| 2013-09-27 00:15 | | J&J warns doctors Doxil shortage will hit next month and more... |
| 2013-09-26 12:15 | | 3 Key Points From Sarepta's Eteplirsen Study Update (And They're Positive) and more... |
| 2013-09-26 00:15 | | Will 3 Versions of Pfizer Be More Valuable Than 1? and more... |
| 2013-09-25 12:15 | | A Closer Look at 4 Pharmaceutical Giants and more... |
| 2013-09-25 00:15 | | Clovis Is Said to Get No Interest After Seeking Buyers and more... |
| 2013-09-24 12:15 | | After cutting jobs, Sequenom says it will consider strategic options for research business and more... |
| 2013-09-20 00:15 | | Sanofi CEO: Thanks to Genzyme, investors take us seriously and more... |
| 2013-09-19 12:15 | | With new tools, Novartis targets brain disease and more... |
| 2013-09-19 00:15 | | Pharma suffers in China as widening scandal spooks docs, reps and more... |
| 2013-09-18 12:15 | | Repros reported additional topline results from study for Androxal and more... |
| 2013-09-18 00:15 | | IPO Preview: Five Prime Therapeutics and more... |
| 2013-09-17 12:15 | | [video]Patent Expirations AbbVie Investors Need to Watch and more... |
| 2013-09-17 00:15 | | Glaxo's Melanoma Drugs Gets FDA Priority Review and more... |
| 2013-09-16 12:15 | | Lufthansa CEO Franz Quits in Surprise Move to Roche and more... |
| 2013-09-16 00:15 | | Drug authority nod to buoy Sun Pharma and more... |
| 2013-09-15 00:15 | | Sun Pharma gets USFDA nod for duodenal ulcer capsules and more... |
| 2013-09-14 12:15 | | Making Sense of the Sunshine Act and more... |
| 2013-09-14 00:15 | | 3 Key Takeaways From Isis' Investor Roadshow Week and more... |
| 2013-09-13 12:15 | | Lilly files $500 million lawsuit against Canada and more... |
| 2013-09-12 12:15 | | Biodel: Creating A Better, Faster Acting Insulin, The Next Big Thing For Diabetic Therapy and more... |
| 2013-09-12 00:15 | | J&J Recalls Some of Schizophrenia Drug After Mold Found and more... |
| 2013-09-11 12:15 | | Baxter makes a smaller buy with $9.5M acquisition of Minn.-based FlowSense and more... |
| 2013-09-11 00:15 | | Novo Nordisk Pushes Ahead In Challenging Year and more... |
| 2013-09-10 12:15 | | Can Stopping This Hedgehog Create New Cancer Treatments? and more... |
| 2013-09-10 00:15 | | Depomed Expands Geographic Scope of License Agreement with Merck for Extended Release Metformin Patents and more... |
| 2013-09-09 12:15 | | J&J Watchdog Employee Can Proceed With Retaliation Lawsuit and more... |
| 2013-09-09 00:15 | | Hey, Celsion - Tell Me Something Good and more... |
| 2013-09-08 12:15 | | The Run Isn't Over for This Booming Biotech and more... |
| 2013-09-08 00:15 | | GSK mulling China withdrawal and more... |
| 2013-09-06 12:15 | | Myriad rolls out next-gen Dx for 8 major cancers and more... |
| 2013-09-06 00:15 | | 4 Healthcare Stock Stories Making Sector Headlines Thursday and more... |
| 2013-09-05 12:15 | | MacroGenics trumpets cancer immunotherapies in $60M IPO pitch and more... |
| 2013-09-05 00:15 | | Patent ruling on Lilly's Alimta lung-cancer drug expected in 2014 and more... |
| 2013-09-04 12:15 | | Judge makes rare move in Merck Fosamax litigation and more... |
| 2013-09-04 00:15 | | How Congress Encourages Shortages Of Cancer Drugs and more... |
| 2013-09-03 12:15 | | Targeting An Untapped Female Sexual Dysfunction Drug Market and more... |
| 2013-09-01 00:15 | | Teva-Rexahn Deal Terminated - Analyst Blog and more... |
